跳至主要内容
临床试验/NCT02022722
NCT02022722Unknown4 期

Assessment Of Pain Subsidence And Sexual Function Amelioration Using Either Pelvic Rehabilitation Or Trigger Point Injections

University of Cincinnati1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2013年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
36
试验地点
1
主要终点
Change in rating of pain from baseline until the end of the study according to the Iowa Pain Scale

研究概览

简要总结

The purpose of this study is to evaluate which treatment option for pelvic floor pain allows for improved sexual function.

详细描述

Pelvic floor pain may be treated with trigger point injections with medications (steroids and local anesthetics) that are FDA approved for injection into muscles. The alternative is a noninvasive treatment option using pelvic rehabilitation which involves vaginal muscle massage. Both treatment options have been used and reported; however, rapidity of improvement and return to normal sexual function have not been assessed. This study assigns patients to either treatment option randomly and the sexual function is assessed based on standardized sexual function questionnaires as well as pain ratings.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • pelvic pain
  • pelvic floor myalgia
  • dyspareunia
  • age > 18 years

排除标准

  • interstitial cystitis
  • vaginal lesions / ulcerations
  • prior trigger point injections in the past 6 months
  • prior pelvic rehabilitation in the past 6 months
  • laparoscopically documented endometriosis / pelvic adhesions or adhesive disease
  • documented pelvic inflammatory disease identified within the past 6 months
  • documented sexually transmitted disease within the past 6 months

研究组 & 干预措施

Pelvic Rehabilitation

Active Comparator

Pelvic Rehabilitation will be conduction on weekly basis for a total of 6 weeks

干预措施: Pelvic Rehabilitation (Procedure)

Trigger Point Injections

Active Comparator

Trigger point injections will be administered on weekly basis for a total of 6 weeks

干预措施: Trigger Point Injections Triamcinolone Acetonide, Bupivacaine Hydrochloride (Drug)

结局指标

主要结局

Change in rating of pain from baseline until the end of the study according to the Iowa Pain Scale

时间窗: Baseline, Week 10

Patients will be asked to rate their current pain prior to initiation of the treatment at the visits, at the start of the study and after the completion of the study, using the 10 point Iowa Pain scale.

次要结局

  • Change in sexual function between visit 1 and visit 10(Baseline, Week 10)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mary South

MD, Director of Female Pelvic Medicine & Reconstructive Surgery

University of Cincinnati

研究点 (1)

Loading locations...

相似试验